Omega Healthcare Investors (OHI) Issues Earnings Results

Omega Healthcare Investors (NYSE:OHI) posted its quarterly earnings results on Tuesday, May 7th. The real estate investment trust reported $0.34 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.71 by ($0.37), Fidelity Earnings reports. The company had revenue of $188.20 million during the quarter, compared to analyst estimates of $190.54 million. Omega Healthcare Investors had a return on equity of 7.02% and a net margin of 30.17%. The company’s revenue was down 2.9% compared to the same quarter last year. During the same period last year, the company posted $0.78 earnings per share. Omega Healthcare Investors updated its FY19 guidance to $3.00-3.12 EPS.

Shares of OHI stock opened at $35.62 on Friday. The firm has a market capitalization of $7.31 billion, a price-to-earnings ratio of 11.72, a price-to-earnings-growth ratio of 4.62 and a beta of 0.46. Omega Healthcare Investors has a 1 year low of $28.65 and a 1 year high of $40.30. The company has a current ratio of 2.86, a quick ratio of 2.86 and a debt-to-equity ratio of 1.16.

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 15th. Shareholders of record on Tuesday, April 30th were paid a $0.66 dividend. The ex-dividend date of this dividend was Monday, April 29th. This represents a $2.64 annualized dividend and a yield of 7.41%. Omega Healthcare Investors’s payout ratio is currently 86.84%.

A number of analysts recently weighed in on OHI shares. Scotiabank started coverage on shares of Omega Healthcare Investors in a report on Thursday, February 7th. They issued a “sector perform” rating and a $39.37 price target for the company. Stifel Nicolaus cut shares of Omega Healthcare Investors from a “buy” rating to a “hold” rating and set a $39.00 price objective on the stock. in a research note on Thursday, February 7th. Zacks Investment Research cut shares of Omega Healthcare Investors from a “buy” rating to a “hold” rating in a research note on Tuesday, February 12th. Finally, ValuEngine cut shares of Omega Healthcare Investors from a “buy” rating to a “hold” rating in a research note on Wednesday, April 3rd. Seven research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Omega Healthcare Investors has an average rating of “Hold” and a consensus target price of $37.05.

In other news, CFO Robert O. Stephenson sold 10,000 shares of the company’s stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $37.00, for a total transaction of $370,000.00. Following the completion of the sale, the chief financial officer now owns 233,326 shares of the company’s stock, valued at approximately $8,633,062. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Ben W. Perks sold 3,000 shares of the firm’s stock in a transaction on Tuesday, March 26th. The shares were sold at an average price of $37.64, for a total transaction of $112,920.00. The disclosure for this sale can be found here. Insiders have sold a total of 75,788 shares of company stock worth $2,810,176 over the last 90 days. 1.65% of the stock is owned by company insiders.

A number of institutional investors have recently modified their holdings of OHI. Rockefeller Capital Management L.P. purchased a new stake in Omega Healthcare Investors in the 1st quarter worth approximately $37,000. Reilly Financial Advisors LLC increased its stake in Omega Healthcare Investors by 68.1% in the first quarter. Reilly Financial Advisors LLC now owns 992 shares of the real estate investment trust’s stock worth $38,000 after purchasing an additional 402 shares during the period. Massey Quick Simon & CO. LLC purchased a new position in shares of Omega Healthcare Investors during the first quarter valued at $38,000. Spirit of America Management Corp NY purchased a new position in Omega Healthcare Investors in the first quarter valued at about $38,000. Finally, JOYN Advisors Inc. grew its stake in Omega Healthcare Investors by 58.4% in the fourth quarter. JOYN Advisors Inc. now owns 1,033 shares of the real estate investment trust’s stock valued at $36,000 after purchasing an additional 381 shares during the last quarter. 69.32% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: This report was published by Rockland Register and is the sole property of of Rockland Register. If you are viewing this report on another website, it was copied illegally and reposted in violation of US and international trademark & copyright legislation. The original version of this report can be viewed at https://rocklandregister.com/2019/06/01/omega-healthcare-investors-ohi-posts-quarterly-earnings-results-misses-expectations-by-0-37-eps.html.

About Omega Healthcare Investors

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.

Read More: Bull Market

Earnings History for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.